Hormone Replacement Therapy Market Poised for a Remarkable US$ 23,729.6 Million Valuation by 2034, Fueled by a Consistent 3.50% CAGR | FMI NEWARK, Del, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The global hormone replacement therapy (HRT) market value is expected to rise from US$ 16,825.2 million in 2024 to US$ 23,729.6 million by 2034. This...

Global Hormone Replacement Therapy Market to Surpass US$ 20,576.3 Million by 2030, Says Coherent Market Insights (CMI) Seattle, July 27, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global hormone replacement therapy market is estimated to be valued at US$ 13,556.7 million in 2022 and is...

Hormone Replacement Therapy Market Is Set to Expand at a CAGR Of 5.7% To reach US$ 27.8 Billion By The Year 2032: FMI Companies Profiled in Hormone Replacement Therapy Market are Eli Lilly and Company, Pfizer, Inc., AbbVie, Inc., Novo Nordisk A/S, Merck KGaA, Mylan N.V., Bayer Healthcare, F. Hoffmann-La Roche Ltd.,...